Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2022-04-24 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于披露2022年第一季度报告的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (410 characters) indicating that the company has disclosed its 2022 first quarter report on a regulatory website. It states the report was approved by the board and is available for investors to review. The document itself does not contain the actual financial data or the full report, but rather serves as a notice that the report has been published and is accessible elsewhere. According to the 'Menu vs Meal' rule, such a brief notice announcing the availability of a report is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2022-04-24 Chinese
2021年年度报告
Annual Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司 2021 年年度报告全文" which translates to "Improve Medical Instruments Co., Ltd. 2021 Annual Report Full Text." It contains detailed sections including company overview, financial data, management discussion and analysis, corporate governance, environmental and social responsibility, shareholding changes, and a full financial report section. The document length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The presence of audited financial statements, management discussion, and detailed financial metrics confirms this is the official annual report for the fiscal year 2021. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-04-24 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 17th meeting of the 5th Board of Directors of 阳普医疗科技股份有限公司. It includes approvals of the 2021 Annual Report, 2021 Financial Statements, profit distribution plan, internal control report, and other management reports. It also mentions that these reports are available on the official disclosure website and that the resolutions will be submitted to the shareholders' meeting for approval. The document is not the actual annual report or financial statements but a board meeting resolution announcement summarizing and approving these reports. The document length is 4320 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Board/Management Information (MANG), as it announces board decisions and management reports rather than containing the full reports themselves.
2022-04-24 Chinese
2022年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司 2022 年第一季度报告全文" which translates to "Yangpu Medical Technology Co., Ltd. 2022 First Quarter Report Full Text." It contains detailed financial data including income statement, balance sheet, cash flow statement, and explanations of financial performance for the first quarter of 2022. The document includes comprehensive financial metrics, management discussion on business operations, risk factors, and shareholder information. It explicitly states it is a quarterly report and includes actual financial statements and substantive financial data. The length of the document (15,000 characters) and the detailed financial content confirm it is not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-04-24 Chinese
独立董事关于第五届董事会第十七次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding a specific board meeting agenda item about related party transactions for the year 2022. It references compliance with stock exchange rules and company bylaws, and it is a pre-approval opinion for a board meeting agenda. The document is short (584 characters) and does not contain financial statements or detailed financial data. It is not an annual report, audit report, or earnings release. It is related to board matters and management oversight. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the board or senior management activities.
2022-04-24 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Yangpu Medical Technology Co., Ltd. It discusses the approval of various reports and proposals including the 2021 Annual Report, 2021 Annual Financial Statements audited by an accounting firm, 2022 Q1 Report, profit distribution plan, internal control self-assessment report, and other corporate governance matters. However, the document itself does not contain the full financial statements or detailed financial data but rather summarizes the resolutions and refers to the full reports being available on the designated disclosure website. The document length is 3560 characters, which is relatively short and consistent with an announcement rather than a full report. The repeated phrase "详见中国证监会指定的创业板信息披露网站巨潮资讯网" (see the full report on the designated disclosure website) indicates this is an announcement of the reports and resolutions rather than the reports themselves. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and references to reports rather than the reports themselves.
2022-04-24 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.